Results 91 to 100 of about 3,177,071 (215)

When psychedelic discourse meets local narrative: Selective uptake of psychedelic meanings surrounding mad honey in Nepal

Addiction, EarlyView.
Abstract Aims ‘Mad honey’ is produced when bees collect nectar from Rhododendron species containing grayanotoxins, naturally occurring diterpenoid toxins that can produce dose‐dependent intoxication. It has long been embedded in Nepalese medicinal and ritual practices but has recently become part of global psychedelic discourse. This study examined how
Sharon R. Sznitman, Surendra Tiwari
wiley   +1 more source

Psychedelic Therapy: Beyond Brain, Embracing Culture

, 2023
This paper argues that cultural embodiment plays a pivotal factor in shaping psychological experiences, influencing both the development and treatment of mental health conditions.
Sofia Tzima, ‪Inês Hipólito‬
core   +1 more source

Participant Experiences of Therapeutic Touch in Psilocybin‐Assisted Therapy

Brain and Behavior
Introduction Although commonly used in psychedelic‐assisted therapy, the role of therapeutic touch remains loosely defined and ethically sensitive.
Rachel Ham, John Gardner, Adrian Carter, Paul Liknaitzky   +3 more
doaj   +1 more source

Breathing in Plants and Chaos—Cosmic Tree Events in Cameroon and Beyond

Anthropology of Consciousness, EarlyView.
ABSTRACT Contemporary practices of tapping into the wisdom of ancestral trees are described through three entangled recent events lived within the context of Bantu practices in Cameroon. In the three instances, the steered or chance encounters with high potency trees were serendipitous telling moments which brought something new to the horizon.
Julie Laplante, Armel Lekeufack, Nina Tamara Barbosa Ponce, Roger Amos Kañaa   +3 more
wiley   +1 more source

Rapid evidence profile #57: Examining the use of psychedelic-assisted psychotherapy for Veterans

, 2023
An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories,
Jaspal, A, DeMaio, P, Waddell, K, Wilson, MG, Velez, CM   +4 more
core  

PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY [PDF]

Psychiatria Fennica
Interest and academic research on psychedelics and psychedelic-assisted therapy in the treatment of psychiatric disorders has increased dramatically in the past two decades. In many ways, psychedelics represent a new therapeutic paradigm in the context
JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
doaj  

Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes

Brain and Behavior
Purpose Psychedelics have received considerable attention due to their potential in treating psychiatric disorders. The “setting” during psychedelic‐assisted therapy (PAT) is recognized as playing a central role in the experience, during which music ...
T. Rowe, T. Hurzeler, E. Towers, E. Louie, K. C. Morley   +4 more
doaj   +1 more source

Safety pharmacology of acute mescaline administration in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber, Mélusine Humbert‐Droz, Laura Ley, Yasmin Schmid, Matthias E. Liechti   +4 more
wiley   +1 more source

Post‐Trial Responsibilities for Participants Implanted With Neurosurgical Devices: A Qualitative Study

Bioethics, EarlyView.
ABSTRACT The issue of post‐trial responsibility is about what is owed to research participants after a clinical trial ends, who is responsible, and how long this responsibility must endure. Despite two decades of international guidance on this issue, research involving novel high‐risk interventions—such as implantable neurotechnologies—raises ...
Nathan Higgins, Adrian Carter, John Gardner   +2 more
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source